EDWARDS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages In...
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Li...
EW LEGAL NEWS: Suffer Losses on Your Edwards Lifesciences Corporation Investment? Contact BFA Law before Expiration of Upcoming December 13 Deadlin...
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and ...
EW INVESTOR DEADLINE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, CA / ACCESSWIRE / October 15, 2024 / The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE:EW) securities betw...
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal se...
EW BREAKING NEWS: Edwards Lifesciences Corporation has been Sued for Securities Fraud; Investors with Losses are Urged to Contact BFA Law about Cla...
Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
Edwards Lifesciences Soars on TTVR Approval, But Challenges Remain
Edwards Lifescience (EW, Financial), a medical device company that specializes in cardiovascular, today by soaring 6% to $68.49 per share at the time this article was written. Technical analysis su...
Is it the Right Time to Hold EW Stock in Your Portfolio Now?
Edward Lifesciences' Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.
Edwards Lifesciences Corporation INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Edwards Lifesciences (EW)
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) co...
EW STOCK ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / September 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) co...
Edwards Lifesciences: Solvable Problems Offer Excellent Opportunities
Edwards Lifesciences faces temporary issues, but its strong market position and competitive edge make it an attractive long-term investment opportunity. The company is transitioning, focusing on it...
Lost Money on Edwards Lifesciences Corporation (EW)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) co...
Lost Money on Edwards Lifesciences Corporation (EW)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) co...
EW Stock Dips Following the Divestiture of Critical Care Wing
Edwards completes the sale of its Critical Care operations and announces a $1 billion share repurchase program.
ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing inve...
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) con...
EW Stock to Benefit From Favorable RHEIA Trial Data on TAVI
Edwards' first all-female TAVI Trial demonstrates favorable outcomes for women receiving Edwards valves.
Related Companies